CLOPIDOGREL
Aortic Valve Disorder
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de QuebecSmall moleculePhase 4 / ApprovedDormant
BBB
74/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 60/ 100
- Competitive Position
- 95/ 100
Competitive context
6 Active assets in the Aortic Valve Disorder cohort.
Same molecule, other indications
CLOPIDOGREL is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →